Power Exercise for Stroke Recovery: The POWER Feasibility Trial
POWER-F
1 other identifier
interventional
15
1 country
1
Brief Summary
Post-stroke deficits are highly common and functional impairment persists throughout life after stroke. Skeletal muscle mass and strength are fundamental contributors to mobility throughout the adult life course. Stroke-related muscle atrophy contributes to loss of strength, and declines in lower extremity function, cardiorespiratory fitness, and walking independence and post-stroke sarcopenia. Improving the quantity and function of skeletal muscle needs to be an important therapeutic target after stroke. Resistance exercise training (RET) has been shown to increase skeletal muscle mass, strength and power, reduce oxidative stress, improve cardiac function, and better regulate lipids after stroke. However, the feasibility and the effects of a power focused RET program for individuals with stroke need to be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Aug 2023
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedNovember 26, 2024
November 1, 2024
10 months
March 20, 2023
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Feasibility: Participant recruitment
Recruitment rates (n/week) and the number of recruited subjects (n) will be reported. Criteria for success include recruitment of ≥1 participant per month and n=15 recruited in ≤13 months.
Through study completion, over 13 months
Feasibility: Sex and gender distribution
Recruitment of males and females, men, women and gender diverse participants will be recorded (n, %). Criteria for success is \<60% (n\<9) of any sex or gender identity.
Through study completion, over 13 months
Feasibility: Attendance and attrition
Percentage of sessions attended (%) and lost to follow-up (n) will be reported. Criteria for success includes ≥85% sessions attended and ≤10% (n\<2) lost to follow-up.
Through study completion, over 13 months
Feasibility: Serious and non-serious adverse events
Number of adverse events (i.e., deaths, serious and non-serious adverse events, n) will be reported. Criteria for success is 0 deaths or serious adverse events and \<5 non-serious adverse events.
Through study completion, over 13 months
Feasibility: Exercise tolerance
Adherence to the prescribed exercises (%) and abnormal blood pressure responses to exercise (n) will be recorded. Criteria for success includes ≥85 of participants performing ≥85% of sets at the prescribed intensity, and ≤25% of weeks experiencing ≥1 abnormal blood pressure response (SBP ≥210 or ≥190 for males and females, respectively).
Through study completion, over 13 months
Feasibility: Satisfaction
Satisfaction will be measured with a 5-point Likert scale (1 = not at all satisfied, 2 = not satisfied, 3 = neither satisfied or not satisfied, 4 = satisfied, and 5 = completely satisfied). Criteria for success is ≥85% of participants reporting being satisfied or completely satisfied with the program.
Immediately post-intervention (week 10)
Secondary Outcomes (8)
Timed up and go test
Baseline (week 0) and post-intervention (week 10)
Short physical performance battery
Baseline (week 0) and post-intervention (week 10)
30-second chair stand test
Baseline (week 0) and post-intervention (week 10)
Isokinetic power
Baseline (week 0) and post-intervention (week 10)
Isokinetic torque
Baseline (week 0) and post-intervention (week 10)
- +3 more secondary outcomes
Study Arms (1)
Power Training
EXPERIMENTALThe program is intentionally designed with 3 progressive phases: Phase 1 Familiarization (Week 1) will allow participants to begin with a low-intensity version of the training program (body weight resisted or light weights at RPE 2-3 for 8 repetitions) to acclimate participants to the movements. Phase 2 Strength (Weeks 2-5) will progress in loads to achieve volitional fatigue between 5-8 repetitions (RPE 7-9). Phase 3 Power (Weeks 6-10) will use intensities between RPE 4-6 (15-20 repetitions) and execute each exercise at the highest possible velocity to focus on muscle power. The exercises, selected to emphasize functional movements relevant to daily activities.
Interventions
Participants will undergo 10 weeks of power-focused resistance training.
Eligibility Criteria
You may qualify if:
- ≥18 years old
- ≥6 months post-stroke
- Able to walk \>10 meters with or without the use of an assistive device
- Living in the community
- Mild to moderate stroke severity (modified Rankin Scale ≤3)
You may not qualify if:
- Any contraindications to exercise for people with cardiovascular disease, such as unstable angina, uncontrolled hypertension, orthostatic blood pressure with exercise, or uncontrolled arrhythmias
- Significant cognitive impairment that would preclude safe exercise participation (Montreal Cognitive Assessment score \<26)
- Actively engaged in stroke rehabilitation services
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Rehabilitation Science
Hamilton, Ontario, L8S1C7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 20, 2023
First Posted
April 18, 2023
Study Start
August 1, 2023
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
November 26, 2024
Record last verified: 2024-11